Broad-spectrum drugs, on the other hand, could limit the spread of a pathogen at an early stage and save many lives. While ...

By Tarun Sai Lomte Evidence shows weak antiviral activity and no improvement in symptom outcomes. Study: Antiviral efficacy ...

In hospitalized COVID-19 patients, azvudine shows lower all-cause mortality and fewer adverse events than Paxlovid, with ...

Between the 2017-2018 and 2023-2024 influenza seasons, the use of antiviral therapy in pediatric patients with influenza declined in both inpatient and outpatient settings.

Historically, COVID-19 symptoms have been fevers or chills, cough, shortness of breath, cough, congestion or a runny nose, ...

The Health Department of Northwest Michigan is reporting an increase in respiratory illnesses across Antrim, Charlevoix, ...

A Texas woman was sentenced Wednesday to one year of probation after she admitted to using fake names to smuggle an unapproved drug from China and Hong Kong into the United to treat a fatal cat ...

Shionogi’s S-892216 is being developed as a pre-exposure prophylaxis (PrEP) drug for Covid-19. Credit: seksan Mongkhonkhamsao ...

An update from Shionogi & Co ( ($JP:4507) ) is now available. Shionogi & Co. has announced that its new drug application for ensitrelvir fumaric ...

Researchers identified how bisphosphonates, used to treat osteoporosis, might reduce Covid-19 risks. Drugs such as ...

Investigators from Mass General Brigham have found that a method originally designed for cancer detection can also identify ...

Shionogi & Co., Ltd. (Head Office: Osaka, Japan; Chief Executive Officer: Isao Teshirogi, Ph.D.; hereafter “Shionogi”) ...